Send mail to Author

Randomized trial of the efficacy and safety of Berotralstat (BCX7353) as an oral prophylactic therapy for hereditary angioedema: results of APeX-2 ihrough 48 weeks (Part 2) (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _____    _    _     ______     ___     _____     __   __  
 /  ___|| | || | ||  /_   _//   / _ \\  |  __ \\   \ \\/ // 
| // __   | || | ||  `-| |,-   | / \ || | |  \ ||   \ ` //  
| \\_\ || | \\_/ ||    | ||    | \_/ || | |__/ ||    | ||   
 \____//   \____//     |_||     \___//  |_____//     |_||   
  `---`     `---`      `-`'     `---`    -----`      `-`'   
                                                            
 


Back to frontdoor view